In this clip, Katherine Tobon, PharmD, BCOP, of Moffitt Cancer Center, defines medically integrated dispensing (MID), how it is implemented in oncology care settings, and the associated advantages and ...

In this episode titled, Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical ...

As stroke systems of care evolve, clinicians are increasingly torn between the known safety of traditional, aggressive ...

The rationale behind the treatment is that, because genetic FXI deficiency has been linked with reduced risk of ischemic ...

Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...

The approval of oral GLP-1 therapies marks a notable evolution in obesity management, expanding therapeutic choice beyond injectable options. Although this development could improve uptake among ...

Shervin Badihian, MD, explains how digital health tools can help boost poststroke activity via reminders, goals, feedback, ...

A population-based study from Sweden upends conventional thinking on when patients with mantle cell lymphoma (MCL) can exhale ...

Under terms announced in December, Cencora acquired shares in OneOncology from TPG and other shareholders for approximately ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.